NCT06109714View on ClinicalTrials.gov

Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 1, 2028

Study Completion Date

December 31, 2028

Conditions
Renal InjuryAcute Kidney Injury
Interventions
OTHER

Goal Directed Fluid Therapy

Fluid administration and hemodynamic management guided with the assistance of Edwards Lifesciences ACUMEN monitor

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT06109714 - Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery | Biotech Hunter | Biotech Hunter